[医药制造业] [2024-04-30]
The Global bariatric surgeries market is estimated to grow at a CAGR of 15.9% from 2022 to 2030. Key factors driving the market growth are the increasing prevalence of obesity and growing demand for minimally invasive surgeries are driving the market growth. However, the stringent regulatory policies and increase in safety concerns restrain the market growth.
[医药制造业,计算机、通信和其他电子设备制造业] [2024-04-30]
The automated external defibrillators market is estimated to grow at a CAGR of 4.5% from 2020 to 2030. Key factors driving the market growth are increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. Whereas performance issues related to automated external defibrillators is hindering the market growth.
[仪器仪表制造业,医药制造业] [2024-04-30]
The global aesthetic lasers market is estimated to grow at a CAGR of 12.3% from 2022 to 2030. Key factors driving the market growth are growing adoption of non-invasive aesthetic procedures and increasing prevalence of skin disorders along with growing awareness about beauty devices. However, risks and complications associated with procedures and stringent safety regulations hinders the market growth.
[医药制造业] [2024-04-30]
据美国国土安全和政府事务委员会官网会议记录,美东时间2024 年3月6日,该委员会以11:1的投票结果通过了S.3558议案。该议案后续仍须经过参众两院投票、总统签署等程序。S.3558是一份禁止与某些生物技术供应商签订合同以及出于其他目的的议案(a bill to prohibit contracting with certain biotechnology providers, and for other purposes),于2023年12月20日由Peters议员提出。Peters议员同时为国土安全和政府事务委员会主席。
[仪器仪表制造业,医药制造业,计算机、通信和其他电子设备制造业] [2024-04-30]
The global endoscopy procedures market is estimated to grow at a CAGR of 7.0% from 2022 to 2030. Key factors driving the market growth are growing preference for minimally invasive surgeries and increasing prevalence of cancer are the key factors driving the market. However, the risks of infections associated with endoscopic procedures hamper the market growth.
[医药制造业] [2024-04-30]
The global cerebrospinal fluid management market is estimated to grow at a CAGR of 5.3% from 2022 to 2030. Key factors driving the market growth are increasing incidences of CSF leak and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.
[仪器仪表制造业,计算机、通信和其他电子设备制造业,医药制造业] [2024-04-30]
The automated external defibrillators market is estimated to grow at a CAGR of 4.5% from 2020 to 2030. Key factors driving the market growth are increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. Whereas performance issues related to automated external defibrillators is hindering the market growth.
[卫生和社会工作,综合,医药制造业] [2024-04-30]
2023年是医改加速深化的一年。由于医药产品及服务的居民福利属性,医药政策改革对医药全产业链的影响尤为明显,逐渐成为影响医药行业估值的最主要因素之一。政策作为未来几年可能影响医药行业发展的最关键指标之一,我们发现市场对于医药政策的趋势认知仍不充分,在投资上极容易受到“不确定性”政策的“突袭”。因此未来,我们将以月度专题的形式,从医药、医疗、医保,三个维度深度梳理、认知医药体系正在发生的变化,以期对改革阶段有更清晰的认知,对长期投资产生更积极的。
[医药制造业] [2024-04-30]
2024年3月,Moderna召开疫苗日活动,公布了其在mRNA疫苗领域的研发布局和最新进展。公司针对呼吸道病毒、潜伏病毒和其他类型的病原体,打造多领域疫苗管线。国内研发方面,各家公司针对多种疾病布局了丰富的疫苗管线,企业间研发实现竞速。批签发方面,24Q1国内疫苗行业整体批签发727批次,带状疱疹疫苗、肺炎疫苗等二类苗产品批签发同比快速增长。预计24Q1疫苗行业整体呈现平稳增长,部分重磅产品有望延续放量趋势。
[医药制造业] [2024-04-30]
系统性红斑狼疮患者人数多,市场空间大,目前仍存在巨大未满足的临床需求,生物制剂是特应性皮炎治疗的下一个重要方向。我国系统性红斑狼疮患者人数达42万-98万人,根据《中国狼疮性肾炎诊断和治疗指南》,我国系统性红斑狼疮人群发病率为 30.13-70.41/10万人,对应SLE患者达42.2万-98.6万人。根据2021年发布于《Nature Reviews Rheumatology》的综述《Global Epidemiology of systemic lupus erythematosus》,北美SLE的发病率达3.7/10万人至49/10万人。2023年美国人口达3.34亿人,对应SLE患者达1.2万-16.4万人。